10-KT XBRL

TRANSITION REPORT

Company: RELMADA THERAPEUTICS, INC.
Filed: March 26, 2020
Period of Report: December 31, 2019
Accession Number: 0001213900-20-007501

View Document ↗ View on SEC.gov ↗